Investor Relations

Investor Relations

We are a biopharmaceutical company focused on the development of novel proprietary therapeutics based on hypoxia inducible factor, or HIF, biology and the commercialization of these products for patients with kidney disease.

Stock Quote

Copyright West LLC. Minimum 15 minutes delayed.

Stock Chart

 
Print Page
Email Page
Contact IR
Email Alerts
Tear Sheet